Bone tissue engineering bioreactors: a role in the clinic?
about
Engineering clinically relevant volumes of vascularized boneBone tissue engineering: recent advances and challengesBioreactor-Based Online Recovery of Human Progenitor Cells with Uncompromised Regenerative Potential: A Bone Tissue Engineering PerspectiveA synergistic approach to the design, fabrication and evaluation of 3D printed micro and nano featured scaffolds for vascularized bone tissue repairCellular and morphological aspects of fibrodysplasia ossificans progressiva. Lessons of formation, repair, and bone bioengineering.Model-based cell number quantification using online single-oxygen sensor data for tissue engineering perfusion bioreactors.Long term perfusion system supporting adipogenesisCystamine-terminated poly(beta-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation.Bioreactors to influence stem cell fate: augmentation of mesenchymal stem cell signaling pathways via dynamic culture systems.Numerical simulation of fluid field and in vitro three-dimensional fabrication of tissue-engineered bones in a rotating bioreactor and in vivo implantation for repairing segmental bone defectsIn vivo bone regeneration using tubular perfusion system bioreactor cultured nanofibrous scaffolds.Perspective on the evolution of cell-based bone tissue engineering strategies.Bioreactor design for tendon/ligament engineering.Review of vascularised bone tissue-engineering strategies with a focus on co-culture systems.Bioreactor engineering of stem cell environmentsModulating the biochemical and biophysical culture environment to enhance osteogenic differentiation and maturation of human pluripotent stem cell-derived mesenchymal progenitors.Concise review: bridging the gap: bone regeneration using skeletal stem cell-based strategies - where are we now?Strategies for improving the physiological relevance of human engineered tissues.Tissue engineering and regenerative medicine in musculoskeletal oncology.Recent Advances in Tissue Engineering Strategies for the Treatment of Joint Damage.Quantitative Validation of the Presto Blue Metabolic Assay for Online Monitoring of Cell Proliferation in a 3D Perfusion Bioreactor System.Bioreactor strategy in bone tissue engineering: pre-culture and osteogenic differentiation under two flow configurations.Advances in regenerative orthopedics.Noninvasive real-time monitoring by alamarBlue(®) during in vitro culture of three-dimensional tissue-engineered bone constructs.Make no bones about it: cells could soon be reprogrammed to grow replacement bones?Human periosteal-derived cell expansion in a perfusion bioreactor system: proliferation, differentiation and extracellular matrix formation.Spatial optimization in perfusion bioreactors improves bone tissue-engineered construct quality attributes.Effects of flow configuration on bone tissue engineering using human mesenchymal stem cells in 3D chitosan composite scaffolds.Orthopaedic regenerative tissue engineering en route to the holy grail: disequilibrium between the demand and the supply in the operating room.Engineering in-vitro stem cell-based vascularized bone models for drug screening and predictive toxicology.
P2860
Q26827780-A030617B-AFCF-4702-BB55-8F5B8FB25F27Q27007788-477D12E0-F578-44A6-A16C-228AD5FB390BQ27320859-0DAF7B24-E076-49D1-ABDE-9CCF4F06A9CFQ28822346-3E8766F8-851E-4C65-8469-DB421C856174Q34452425-92017930-F5F0-4A40-B0C4-ABEC77740AC7Q35158358-5C72419D-AE3E-4F0D-A31B-9CAA5569F9FBQ35920895-0DF364E6-F09F-4C79-9D10-AE1BF6207565Q36204816-7379C334-C681-439A-93A2-5350205F4087Q36287687-A3270F6E-4431-4AE9-9713-94EE47DFA5B3Q36636460-08E94E30-3C52-4999-84A3-499C46793EF3Q37419300-F1411E3D-677C-460F-8C6A-A7BB6F685223Q38026457-EA476648-F27E-41AB-BF1E-0315F5C0A71AQ38052609-606C654E-28CC-4C21-874B-63161B012173Q38061097-5CE408C2-165D-4F2C-9D5E-A2826E72AD2AQ38093335-51514123-0F71-48E8-A418-8134DED884CBQ38134206-F1789FDF-A653-408C-AFE0-F9CF6316523AQ38151642-C7F6DF04-6EDE-4055-89AE-FF35A18785C7Q38456489-7F5C1306-0600-48FD-BCC4-24AC903B8519Q38938423-F6035FA9-E2B7-490D-95C9-C7E4ADE60458Q39440962-D523728D-7475-4259-A67F-7FC7091CC351Q41021346-D11D529F-6CB6-4D09-A6D3-89AB61E2A412Q41672756-C4F9CD47-AEE0-49F8-8F31-78038E11860EQ42968649-CFBD5E93-D06C-4622-96FA-77C8F97C6095Q43080234-86EC7300-62C7-4325-97BF-6D4D4873E6E9Q44108031-C5E7353F-4951-4BFA-8F56-7BD7258ACC29Q53023080-89B2D32A-BE7B-4888-854D-09D871A7F6B3Q53044467-07C358B3-C42C-419B-A947-A71843400BABQ53361249-6C77E4C8-5ED3-4146-9C51-DF25A1A5CCF4Q55085425-9150D606-4D51-4AAE-92BC-CD351974B94DQ55378702-73E8E92B-B1BD-446A-944C-EE4F0F9CD8E4
P2860
Bone tissue engineering bioreactors: a role in the clinic?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Bone tissue engineering bioreactors: a role in the clinic?
@en
Bone tissue engineering bioreactors: a role in the clinic?
@nl
type
label
Bone tissue engineering bioreactors: a role in the clinic?
@en
Bone tissue engineering bioreactors: a role in the clinic?
@nl
prefLabel
Bone tissue engineering bioreactors: a role in the clinic?
@en
Bone tissue engineering bioreactors: a role in the clinic?
@nl
P2093
P1476
Bone tissue engineering bioreactors: a role in the clinic?
@en
P2093
Daphne Hutton
Erin Salter
Nalinkanth Ghone
Warren L Grayson
P356
10.1089/TEN.TEB.2011.0209
P577
2012-01-04T00:00:00Z